Welcome to closing bell. I'm Scott Wobner, live from Post 9 here at the New York Stock Exchange.

This maker breakout begins with the uncertain road ahead. The market's more defensive stance lately,

and whether it's a worrisome sign now for stocks. We'll ask our experts over this final stretch.

In the meantime, your scorecard today is not a pretty one with 60 minutes to go in regulation.

It's another down day for the majors. The selling pretty split as well. You can see the

NASDAQ is off. The Russell's down almost 3%. But the NASDAQ's ugly today. The other majors are

down. United Healthcare, the big blow to the Dow today on that report that the Justice Department is probing

part of the company's business. We'll follow it. It's down 7%. Invitya is down ahead of its

pivotal earnings report next week. We are watching that closely too, and we will in this last

hour. Palantir's rough week continuing today. Shares are down yet again. Many momentum names

are following suit. It is also worth taking a look at where yields are at 301 in the east today.

There's yields. They are falling across the curve. So you have a flight to safety today in some respects as well.

The VIX is reflecting the mood of the market. It is a spike

higher today. There it is by almost 20%. It does take us to our talk of the tape. Are cracks forming

in the bullcase for stocks? Let's ask our panel that question. Stephanie Link, Hightower's chief

investment strategist and portfolio manager, Cameron Dawson,

chief investment officer for New Edge Wealth and Malcolm Etheridge, Capital Area Planning

Groups Managing Partner.

Steph and Malcolm are CNBC contributors.

It's good to have everybody here.

We start on the desk, Steph.

What do you make of this sell-off?

...